Medical Condition News

RSS

Speaker Pelosi praises Obama's announcement to help veterans with PTSD get easier access to treatment

Speaker Nancy Pelosi released the following statement today praising President Obama's announcement that the Department of Veterans Affairs will start making it easier for veterans with Post Traumatic Stress Disorder to receive critical health and disability benefits and treatment:

13 Jul 2010

Line of moisture absorber products available to eliminate dampness that enables mold to grow

The stifling humidity accompanying this summer's extreme temperatures increases the chance that homeowners will experience significant indoor humidity and moisture that may lead to musty odors, allergens, and mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

13 Jul 2010

Researchers watch armed tumor-seeking immune system cells attack dangerous melanomas in real time

Researchers at UCLA's Jonsson Comprehensive Cancer Center created a large, well armed battalion of tumor-seeking immune system cells and watched, in real time using Positron Emission Tomography (PET), as the special forces traveled throughout the body to locate and attack dangerous melanomas.

13 Jul 2010

Memoir traces lifelong, undetected bipolar disorder

When Jerry Jewler turned 60, he celebrated his "coming of age" with a splashy party -- and a glorious high. The next day, he awoke to a hell he had never known: sad and depressed, unable to make even idle chatter with his houseguests, and angry at the world.

13 Jul 2010

Research finding could yield new ideas for treating symptoms of motor neurone disease

Scientists in Aberdeen have discovered a mechanism that muscles use to regulate the nerves which control them. They believe their finding could yield new ideas for treating symptoms of motor neurone disease - a progressive and incurable neurodegenerative condition that leads to muscle weakness and wasting - and other neuromuscular conditions.

13 Jul 2010

AlphaRx reports positive preclinical results of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke

AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.

13 Jul 2010

OSDUHS Mental Health and Well-Being Report reveals important trends in overall health of students

An ongoing survey of Ontario students in Grades 7 to 12 conducted for the Centre for Addiction and Mental Health shows that the number of students who rate their health as poor has significantly increased over the past two decades. The 2009 Ontario Student Drug Use and Health Survey Mental Health and Well-Being Report released today reveals important trends in mental health, physical health, and risk behaviours among Ontario students.

13 Jul 2010

New approach in treating heart attack, cardiomyopathy using stem cells

Presenting at the UK National Stem Cell Network annual science conference today (13 July), Professor Michael Schneider describes a new approach to treating heart attack and cardiomyopathy using stem cells.

13 Jul 2010

Ophthalmology professor receives $60,000 RPB award to research Sjogren's syndrome

Hui Shao, MD, PhD, associate professor of ophthalmology and visual sciences at the University of Louisville School of Medicine, has received a $60,000 Lew R. Wasserman Merit Award from the Research to Prevent Blindness (RPB) organization. The grant will help fund Shao's research of Sjogren's syndrome, a chronic autoimmune disease that targets the salivary and lacrimal glands - the glands that produce saliva and tears, respectively - resulting in dry mouth and dry eye symptoms.

13 Jul 2010

LLS awards two new grants through prestigious Marshall A. Lichtman SCOR research initiative

The Leukemia & Lymphoma Society today announced it has awarded two new grants through its prestigious Marshall A. Lichtman Specialized Center of Research research initiative, bringing the program's total funding to $210.5 million since its inception in 2000.

13 Jul 2010

Doctors should use diffusion MRI scan to diagnose stroke, says new guideline

Doctors should use a diffusion MRI scan to diagnose stroke instead of a CT scan, according to a new guideline from the American Academy of Neurology. The guideline is published in the July 13, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

13 Jul 2010

Silicon oil appears to protect vision in patients undergoing radiation therapy for ocular melanoma: Study

Eye cancer patients face an unenviable dilemma. They must enter treatment knowing that their surgeon's strategy to kill the deadly tumor with radiation may also sacrifice their eyesight.

13 Jul 2010

Gene mutation that causes auditory neuropathy identified

Researchers have identified a gene mutation that causes a rare form of hearing loss known as auditory neuropathy, according to U-M Medical School scientists.

13 Jul 2010

TLR7, TLR9 proteins could be culprit behind lupus patients' resistance to steroid treatments: Scientists

Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide.

13 Jul 2010

History of sexual abuse associated with lifetime diagnosis of multiple psychiatric disorders

New research finds that a history of sexual abuse, regardless of the victim's gender or age when the abuse occurred, correlates strongly with a lifetime diagnosis of multiple psychiatric disorders.

13 Jul 2010

Roche obtains global co-exclusive license for PI3K biomarker from QIAGEN

Roche announced today that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays. Johns Hopkins University owns the patent for the PI3K biomarker and has previously granted an exclusive license to QIAGEN's wholly owned subsidiary DxS, now QIAGEN Manchester.

From QIAGEN Manchester Limited 13 Jul 2010

Amorfix Life Sciences uses A(4) test to detect accumulation of Abeta in mouse models of AD

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases including Alzheimer's disease, has used its A(4) test to compare the rate of accumulation of aggregated Abeta in the brain tissue of various mouse models of AD. Amorfix presented this new data at the International Conference on Alzheimer's Disease this week.

13 Jul 2010

MagnaCare social networking campaigns raise awareness of personal health, preventive care

MagnaCare, a health plan services company with national reach, today announces that its ongoing social networking campaigns are successfully raising awareness of the importance of personal health improvement and preventive care, emphasizing issues that sometimes fall between the cracks of larger causes, and advancing the MagnaCare commitment to "Care Right Here."

13 Jul 2010

Biodel reports preclinical test results of BIOD620 glucose-regulated or "smart" basal insulin product candidate

Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to Lantus® (insulin glargine).

13 Jul 2010

New study on impact of bortezomib on mantle cell lymphoma

A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADE-), the first in a new class of cancer drugs known as proteasome inhibitors, works in mantle cell lymphoma. The study also provides preliminary evidence for which patients might benefit most from bortezomib.

13 Jul 2010

Medical Condition News

Speaker Pelosi praises Obama's announcement to help veterans with PTSD get easier access to treatment

Line of moisture absorber products available to eliminate dampness that enables mold to grow

Researchers watch armed tumor-seeking immune system cells attack dangerous melanomas in real time

Memoir traces lifelong, undetected bipolar disorder

Research finding could yield new ideas for treating symptoms of motor neurone disease

AlphaRx reports positive preclinical results of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke

OSDUHS Mental Health and Well-Being Report reveals important trends in overall health of students

New approach in treating heart attack, cardiomyopathy using stem cells

Ophthalmology professor receives $60,000 RPB award to research Sjogren's syndrome

LLS awards two new grants through prestigious Marshall A. Lichtman SCOR research initiative

Doctors should use diffusion MRI scan to diagnose stroke, says new guideline

Silicon oil appears to protect vision in patients undergoing radiation therapy for ocular melanoma: Study

Gene mutation that causes auditory neuropathy identified

TLR7, TLR9 proteins could be culprit behind lupus patients' resistance to steroid treatments: Scientists

History of sexual abuse associated with lifetime diagnosis of multiple psychiatric disorders

Roche obtains global co-exclusive license for PI3K biomarker from QIAGEN

Amorfix Life Sciences uses A(4) test to detect accumulation of Abeta in mouse models of AD

MagnaCare social networking campaigns raise awareness of personal health, preventive care

Biodel reports preclinical test results of BIOD620 glucose-regulated or "smart" basal insulin product candidate

New study on impact of bortezomib on mantle cell lymphoma

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News